InvestorsHub Logo
Followers 33
Posts 5264
Boards Moderated 0
Alias Born 01/23/2019

Re: None

Tuesday, 11/21/2023 5:37:34 PM

Tuesday, November 21, 2023 5:37:34 PM

Post# of 424170
This article should be forwarded to the CEO of amarin or whoever would make a major decision to change the name of Vascepa to something more relevant relating to CVD prevention in the USA this move may get rid of the generic issue of infringement. Retain the Vascepa brand for HTG and rebrand the FDA approved Vascepa for CVD to a more relevant name!!!
Does anyone have a contact name within the company? Capt maybe????
https://endpts.com/why-did-lilly-give-tirzepatide-a-new-name-for-obesity-hint-its-the-marketing/
Feedback please....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News